technetium tc 99m sestamibi has been researched along with toremifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, KS; Glass, DM; Harrington, KJ; Lalani, el-N; Mubashar, M; Peters, AM; Sinnett, D; Stamp, GW | 1 |
| Chaudhary, KS; Harrington, KJ; Lalani, el-N; Mubashar, M; Peters, AM; Stamp, GW | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and toremifene
| Article | Year |
|---|---|
99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily B; Breast; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Immunohistochemistry; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Selective Estrogen Receptor Modulators; Technetium Tc 99m Sestamibi; Toremifene | 2002 |
Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Microscopy, Fluorescence; Technetium Tc 99m Sestamibi; Toremifene; Vinblastine | 2004 |